MBIO DIAGNOSTICS, INC.

Profile

Company Names

MBIO DIAGNOSTICS, INC.

Addresses

5603 ARAPAHOE AVENU, SUITE 1, BOULDER, CO 80303

5603 ARAPAHOE AVENUE, SUITE 1, BOULDER, CO 80303

5603 ARAPAHOE AVENUE, SUITE 100, BOULDER, CO 80303

5603 ARAPAHOE AVENUE, SUITE 1, BOULDER, CO 80303-1377

3122 STERLING CIRCLE, SUITE 100, BOULDER, CO 80301

Phone Numbers

303-952-2905
3039522905
303-952-2863
3039522863

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY, OTHER, MANUFACTURING

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$45,261,061.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2022-02-18 
$6,120,000.00 
$9,000,000.00 
$2,880,000.00 
Debt 
11
2021-03-05 
$1,725,000.00 
$4,000,000.00 
$2,275,000.00 
Debt 
10
2021-02-01 
$9,990,000.00 
$9,990,000.00 
$0.00 
Debt 
9
2020-07-17 
$6,146,350.00 
$11,000,000.00 
$4,853,650.00 
Equity 
8
2020-02-05 
$1,585,000.00 
$3,000,000.00 
$1,415,000.00 
Debt 
7
2018-08-08 
$5,206,032.00 
$6,422,500.00 
$1,216,468.00 
Equity 
6
2018-05-09 
$1,105,000.00 
$1,500,000.00 
$395,000.00 
Debt 
5
2017-12-19 
$620,000.00 
$620,000.00 
$0.00 
Debt 
4
2016-08-17 
$562,500.00 
$2,250,000.00 
$1,687,500.00 
Equity 
3
2015-05-07 
$6,334,255.00 
$6,334,255.00 
$0.00 
Equity 
2
2012-08-17 
$3,869,500.00 
$3,869,500.00 
$0.00 
Equity 
1
2010-12-21 
$1,997,424.00 
$1,997,424.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MILTON 
 
CHANG 
DIRECTOR
MILTON 
CHANG 
DIRECTOR
MILTON 
J. 
CHANG 
DIRECTOR
ANDREW 
 
DRENICK 
DIRECTOR
SARAH 
 
HATCHER 
EXECUTIVE OFFICER
SARAH 
HATCHER 
EXECUTIVE OFFICER
SARAH 
C. 
HATCHER 
EXECUTIVE OFFICER
SARAH 
HATCHER 
EXECUTIVE OFFICER
MICHAEL 
J. 
LOCHHAED 
EXECUTIVE OFFICER
MICHAEL 
 
LOCHHEAD 
EXECUTIVE OFFICER
MICHAEL 
LOCHHEAD 
EXECUTIVE OFFICER
MICHAEL 
J. 
LOCHHEAD 
EXECUTIVE OFFICER
CHRIS 
 
MYATT 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
 
MYATT 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
MYATT 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
J. 
MYATT 
EXECUTIVE OFFICER, DIRECTOR
JUDITH 
 
O-BRIEN 
DIRECTOR
ROBERT 
SILVERMAN 
DIRECTOR
ROBERT 
J. 
SILVERMAN 
DIRECTOR
NICK 
 
TRAGGIS 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-02-18 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-03-05 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-02-01 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-17 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-05 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-05 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-05 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-08 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-09 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-19 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-07 
D
MANUFACTURING 
 
$1,000,001 - $5,000,000 
Equity 
2012-08-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#